Home >> Research Area >>Natural Products>>Alkaloids>> Aristolactam AIIIa

Aristolactam AIIIa

CAS# 97399-91-2

Aristolactam AIIIa

Catalog No. BCN4521----Order now to get a substantial discount!

Product Name & Size Price Stock
Aristolactam AIIIa: 5mg $886 In Stock
Aristolactam AIIIa: 10mg Please Inquire In Stock
Aristolactam AIIIa: 20mg Please Inquire Please Inquire
Aristolactam AIIIa: 50mg Please Inquire Please Inquire
Aristolactam AIIIa: 100mg Please Inquire Please Inquire
Aristolactam AIIIa: 200mg Please Inquire Please Inquire
Aristolactam AIIIa: 500mg Please Inquire Please Inquire
Aristolactam AIIIa: 1000mg Please Inquire Please Inquire

Quality Control of Aristolactam AIIIa

Number of papers citing our products

Chemical structure

Aristolactam AIIIa

3D structure

Chemical Properties of Aristolactam AIIIa

Cas No. 97399-91-2 SDF Download SDF
PubChem ID 10356352 Appearance Yellow powder
Formula C16H11NO4 M.Wt 281.3
Type of Compound Alkaloids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
SMILES COC1=C(C=C2C3=C(C=C4C=CC(=CC4=C31)O)NC2=O)O
Standard InChIKey PFXGXKFPTAJYHV-UHFFFAOYSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Aristolactam AIIIa

The herbs of Aristolochia debilis Sieb. et Zucc

Biological Activity of Aristolactam AIIIa

Description1. Aristolactam AIIIa has anti-tumor activity. 2. Aristolactam AIIIa was identified as a new type of Plk1 inhibitors, targeting the Polo Box domain (PBD). 3. Aristolactam IIIa shows inhibition of platelet aggregation induced by collagen or arachidonic acid.
TargetsCDK | MAPK

Aristolactam AIIIa Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Aristolactam AIIIa Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Aristolactam AIIIa

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.5549 mL 17.7746 mL 35.5492 mL 71.0985 mL 88.8731 mL
5 mM 0.711 mL 3.5549 mL 7.1098 mL 14.2197 mL 17.7746 mL
10 mM 0.3555 mL 1.7775 mL 3.5549 mL 7.1098 mL 8.8873 mL
50 mM 0.0711 mL 0.3555 mL 0.711 mL 1.422 mL 1.7775 mL
100 mM 0.0355 mL 0.1777 mL 0.3555 mL 0.711 mL 0.8887 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Aristolactam AIIIa

The natural product Aristolactam AIIIa as a new ligand targeting the polo-box domain of polo-like kinase 1 potently inhibits cancer cell proliferation.[Pubmed:19801998]

Acta Pharmacol Sin. 2009 Oct;30(10):1443-53.

AIM: To search for novel inhibitors of human polo-like kinase 1 (Plk1), which plays important roles in various aspects of mitotic progression and is believed as a promising anti-cancer drug target, and further investigate the potential inhibition mechanism of active compounds against Plk1, thus developing potent anti-tumor lead compounds. METHODS: Surface plasmon resonance (SPR) technology-based assay and enzymatic inhibition assay were used to screen Plk1 inhibitors. Sulphorhodamine B (SRB)-based assay, flow cytometry, confocal microscopy and Western blotting were used to further identify the potent Plk1 inhibitor. To investigate the inhibitory mechanism of the active compound against Plk1, enzymatic inhibition assay, SPR and yeast two-hybrid technology-based assays were used. RESULTS: Aristolactam AIIIa was identified as a new type of Plk1 inhibitors, targeting the Polo Box domain (PBD) which is another efficient tactic for exploring Plk1 inhibitors. Further studies indicated that it could block the proliferations of HeLa, A549, HGC and the HCT-8/V cells (clinical Navelbine-resistant cancer cell), induce mitotic arrest of HeLa cells at G2/M phase with spindle abnormalities and promote apoptosis in HeLa cells. The results from SPR and yeast two-hybrid technology-based assays suggested that it could target both the catalytic domain of Plk1 (CD) and PBD and enhance the CD/PBD interaction. CONCLUSION: Our current work is expected to shed light on the potential anti-tumor mechanism of Aristolactam AIIIa, and this natural product might be possibly used as a lead compound for further developing anti-tumor drugs.

Keywords:

Aristolactam AIIIa,97399-91-2,Natural Products, buy Aristolactam AIIIa , Aristolactam AIIIa supplier , purchase Aristolactam AIIIa , Aristolactam AIIIa cost , Aristolactam AIIIa manufacturer , order Aristolactam AIIIa , high purity Aristolactam AIIIa

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: